Sunday March 21 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z
ALS Amyotrophic Lateral Sclerosis News and Headlines
ALS Amyotrophic Lateral Sclerosis News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's ALS Amyotrophic Lateral Sclerosis news alerts.
Site Map > Biotechnology News > Health News > ALS Amyotrophic Lateral Sclerosis

ALS victims still looking for answers
Cookeville Herald-Citizen:  similar ...
Medical News: Cytokinetics Announces Opening Of A Phase IIa "Evidence Of Effect" Clinical Trial Of CK-2017357 For Patients With Amyotrophic Lateral Sclerosis
BioFind:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of ...
PR-USA.net:  similar ...
Cytokinetics Announces Opening Of A Phase IIa 'Evidence Of Effect' Clinical Trial Of CK-2017357 For Patients W
Medical News Today:  similar ...
Cytokinetics In Phase IIa Clinical Trial For ALS Drug- Update
RTTNews.com:  similar ...
Trophos Completes Patient Enrolment In Pivotal Phase 3 Efficacy Study Of Olesoxime In Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
Medical News Today:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral ..
PR inside:  similar ...
Trophos Completes Patient Enrolment in Pivotal Phase 3 Efficacy Study of Olesoxime in Amyotrophic Lateral Scle
Bionity.com:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
Genetic Engineering News:  similar ...
Medical News: Trophos Completes Patient Enrolment In Pivotal Phase 3 Efficacy Study Of Olesoxime In Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
BioFind:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
FOXBusiness.com:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
FOXBusiness.com:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
Pharmacy Choice:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
Sys-Con Media:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
Street Insider:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
Stockwatch:  similar ...
Cytokinetics Announces Opening of a Phase IIa 'Evidence of Effect' Clinical Trial of CK-2017357 for Patients W
NewsBlaze:  similar ...
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic L
TradingMarkets:  similar ...
Cytokinetics, Inc. (CYTK) Announces Opening of a Phase IIa 'Evidence of Effect' Clinical Trial of CK-2017357 f
BioSpace:  similar ...
Cytokinetics Announces Opening of a Phase IIa 'Evidence of Effect' Clinical Trial of CK-2017357 for Patients W
Therapeutics Daily:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 
BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.